Compare Immunovant Inc. Common Stock (IMVT) vs RingCentral Inc. Class A Common Stock (RNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs RingCentral Inc. Class A Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while RingCentral Inc. Class A Common Stock trades at $78.59 (market cap $6.39B). The key difference: Immunovant Inc. Common Stock and RingCentral Inc. Class A Common Stock are close in size by market cap, and RingCentral Inc. Class A Common Stock pays a 0.36% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and RingCentral Inc. Class A Common Stock for 0 Days on average.
| IMVT | RNG | |
|---|---|---|
Market Cap | $6.62B | $6.39B |
Volume | 1,131,364 | 1,087,767 |
Sector | Health | Technology |
52-Week High | $44.96 | $79.82 |
52-Week Low | $17.03 | $24.82 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $7.44B |
Dividend Yield | — | 0.36% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About RingCentral Inc. Class A Common Stock
RingCentral provides cloud-based business communications and contact center solutions. Its platform combines phone, messaging, video meetings, and customer-service tools.
Read more on RNG →
